ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY Trademark

Trademark Overview


On Friday, April 8, 2005, a trademark application was filed for ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY with the United States Patent and Trademark Office. The USPTO has given the ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY trademark a serial number of 76635438. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, November 18, 2017. This trademark is owned by Associated Regional and University Pathologists, Inc.. The ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Clinical laboratory services, reference laboratory services, diagnostic laboratory services, medical laboratory services, and providing medical laboratory information online over the global communications network, all in the fields of pathology, clinical pathology, anatomic pathology, histopathology, histology, infectious diseases, disease pathology, infectious disease pathology, staining analysis, virology, hematopathology, hematology, proteomics, hemostasis, thrombosis, flow analysis, flow cytometry, capillary electrophoresis, genetics, molecular genetics, biochemical genetics, genetic diseases, gene identification, gene sequencing, nucleotide sequencing, genotypic identification, phenotypic identification, probe synthesis, gene therapy, mass spectrometry, tandem mass spectrometry, molecular testing, molecular diagnostics, molecular evaluation, cytopathology, cytology, cytogenetics, oncology, tumor detection, tumor markers, tumor diagnostics, mutation detection, mutation analysis, mo...

Medical testing services in the fields of pathology, clinical pathology, anatomic pathology, histopathology, histology, infectious diseases, disease pathology, infectious disease pathology, staining analysis, virology, hematopathology, hematology, proteomics, hemostasis, thrombosis, flow analysis, flow cytometry, capillary electrophoresis, genetics, molecular genetics, biochemical genetics, genetic diseases, gene identification, gene sequencing, nucleotide sequencing, genotypic identification, phenotypic identification, probe synthesis, mass spectrometry, tandem mass spectrometry, molecular testing, molecular diagnostics, molecular evaluation, cytopathology, cytology, cytogenetics, oncology, tumor detection, tumor markers, tumor diagnostics, mutation detection, mutation analysis, morphologic change, immunopathology, immunology, immunohematology, immunohistochemical staining, immunofluorescence, autoimmune disorders, microbiology, serology, microbial serology, endocrinology, clinical ch...
arup institute for clinical and experimental pathology

General Information


Serial Number76635438
Word MarkARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY
Filing DateFriday, April 8, 2005
Status800 - REGISTERED AND RENEWED
Status DateSaturday, November 18, 2017
Registration Number3315105
Registration DateTuesday, October 23, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 7, 2007

Trademark Statements


Disclaimer with Predetermined Text"INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY"
Goods and ServicesClinical laboratory services, reference laboratory services, diagnostic laboratory services, medical laboratory services, and providing medical laboratory information online over the global communications network, all in the fields of pathology, clinical pathology, anatomic pathology, histopathology, histology, infectious diseases, disease pathology, infectious disease pathology, staining analysis, virology, hematopathology, hematology, proteomics, hemostasis, thrombosis, flow analysis, flow cytometry, capillary electrophoresis, genetics, molecular genetics, biochemical genetics, genetic diseases, gene identification, gene sequencing, nucleotide sequencing, genotypic identification, phenotypic identification, probe synthesis, gene therapy, mass spectrometry, tandem mass spectrometry, molecular testing, molecular diagnostics, molecular evaluation, cytopathology, cytology, cytogenetics, oncology, tumor detection, tumor markers, tumor diagnostics, mutation detection, mutation analysis, morphologic change, immunopathology, immunology, immunohematology, immunohistochemical staining, inununofluorescence, autoimmune disorders, microbiology, serology, microbial serology, endocrinology, clinical chemistry, toxicology, clinical toxicology, toxins, pharmacogenomics, therapeutic drugs, transplantation pathology, surgical pathology, autopsy pathology, metabolics, metabolic status, nutritional status, microscopy, core lab testing, engineering analysis, laboratory automation, medical informatics, and health care; clinical laboratory services, reference laboratory services, dissection laboratory services, diagnostic laboratory services, medical laboratory services, veterinary laboratory services, and medical and scientific research, namely, collecting, processing, treating, freezing, staining, dissecting, analyzing, screening, testing, typing and storing of biological substances and human and animal tissue, blood, blood components, cells, stems cells, abnormal cells, chromosomes and nucleic acid; development, improvement, evaluation, analysis and application of clinical laboratory tests and diagnostics in the fields of pathology, clinical pathology, anatomic pathology, histopathology, histology, infectious diseases, disease pathology, infectious disease pathology, staining analysis, virology, hematopathology, hematology, proteomics, hemostasis, thrombosis, flow analysis, flow cytometry, capillary electrophoresis, genetics, molecular genetics, biochemical genetics, genetic diseases, gene identification, gene sequencing, nucleotide sequencing, genotypic identification, phenotypic identification, probe synthesis, mass spectrometry, tandem mass spectrometry, molecular testing, molecular diagnostics, molecular evaluation, cytopathology, cytology, cytogenetics, oncology, tumor detection, tumor markers, tumor diagnostics, mutation detection, mutation analysis, morphologic change, immunopathology, immunology, immunohematology, immunohistochemical staining, immunofluorescence, autoimmune disorders, microbiology, serology, microbial serology, endocrinology, clinical chemistry, toxicology, clinical toxicology, toxins, pharmacogenomics, therapeutic drugs, transplantation pathology, surgical pathology, autopsy pathology, metabolics, metabolic status, nutritional status, microscopy, core lab testing, engineering analysis, laboratory automation, medical informatics, and health care; and medical research in the fields of pathology, clinical pathology, anatomic pathology, histopathology, histology, infectious diseases, disease pathology, infectious disease pathology, staining analysis, virology, hematopathology, hematology, proteomics, hemostasis, thrombosis, flow analysis, flow cytometry, capillary electrophoresis, genetics, molecular genetics, biochemical genetics, genetic diseases, gene identification, gene sequencing, nucleotide sequencing, genotypic identification, phenotypic identification, probe synthesis, mass spectrometry, tandem mass spectrometry, molecular testing, molecular diagnostics, molecular evaluation, cytopathology, cytology, cytogenetics, oncology, tumor detection, tumor markers, tumor diagnostics, mutation detection, mutation analysis, morphologic change, immunopathology, immunology, immunohematology, immunohistochemical staining, immunofluorescence, autoimmune disorders, microbiology, serology, microbial serology, endocrinology, clinical chemistry, toxicology, clinical toxicology, toxins, pharmacogenomics, therapeutic drugs, transplantation pathology, surgical pathology, autopsy pathology, metabolics, metabolic status, nutritional status, microscopy, core lab testing, engineering analysis, laboratory automation, medical informatics, and health care
Goods and ServicesMedical testing services in the fields of pathology, clinical pathology, anatomic pathology, histopathology, histology, infectious diseases, disease pathology, infectious disease pathology, staining analysis, virology, hematopathology, hematology, proteomics, hemostasis, thrombosis, flow analysis, flow cytometry, capillary electrophoresis, genetics, molecular genetics, biochemical genetics, genetic diseases, gene identification, gene sequencing, nucleotide sequencing, genotypic identification, phenotypic identification, probe synthesis, mass spectrometry, tandem mass spectrometry, molecular testing, molecular diagnostics, molecular evaluation, cytopathology, cytology, cytogenetics, oncology, tumor detection, tumor markers, tumor diagnostics, mutation detection, mutation analysis, morphologic change, immunopathology, immunology, immunohematology, immunohistochemical staining, immunofluorescence, autoimmune disorders, microbiology, serology, microbial serology, endocrinology, clinical chemistry, toxicology, clinical toxicology, toxins, pharmacogenomics, therapeutic drugs, transplantation pathology, surgical pathology, autopsy pathology, metabolics, metabolic status, nutritional status, microscopy, core lab testing, engineering analysis, laboratory automation, medical informatics, and health care; and providing medical information online over a global communications network in the fields of pathology, clinical pathology, anatomic pathology, histopathology, histology, infectious diseases, disease pathology, infectious disease pathology, staining analysis, virology, hematopathology, hematology, proteomics, hemostasis, thrombosis, flow analysis, flow cytometry, capillary electrophoresis, genetics, molecular genetics, biochemical genetics, genetic diseases, gene identification, gene sequencing, nucleotide sequencing, genotypic identification, phenotypic identification, probe synthesis, mass spectrometry, tandem mass spectrometry, molecular testing, molecular diagnostics, molecular evaluation, cytopathology, cytology, cytogenetics, oncology, tumor detection, tumor markers, tumor diagnostics, mutation detection, mutation analysis, morphologic change, immunopatho logy, immunology, immunohematology, immunohistochemical staining, immunofluorescence, autoimmune disorders, microbiology, serology, microbial serology, endocrinology, clinical chemistry, toxicology, clinical toxicology, toxins, pharmacogenomics, therapeutic drugs, transplantation pathology, surgical pathology, autopsy pathology, metabolics, metabolic status, nutritional status, microscopy, core lab testing, engineering analysis, laboratory automation, medical informatics, and health care
Pseudo MarkASSOCIATE REGIONAL AND UNIVERSITY PATHOLOGISTS INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 20, 2005
Primary Code042
First Use Anywhere DateWednesday, March 1, 2000
First Use In Commerce DateWednesday, March 1, 2000

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 12, 2006
Primary Code044
First Use Anywhere DateWednesday, March 1, 2000
First Use In Commerce DateWednesday, March 1, 2000

Trademark Owner History


Party NameARUP LABORATORIES, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSALT LAKE CITY, UT 84108

Party NameAssociated Regional and University Pathologists, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84108

Party NameAssociated Regional and University Pathologists, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84108

Party NameAssociated Regional and University Pathologists, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84108

Trademark Events


Event DateEvent Description
Saturday, November 18, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED
Saturday, November 18, 2017REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, November 18, 2017REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, November 18, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, October 23, 2017TEAS SECTION 8 & 9 RECEIVED
Wednesday, February 5, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
Tuesday, February 4, 2014REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, January 23, 2014REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Tuesday, February 4, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, January 23, 2014PAPER RECEIVED
Wednesday, March 20, 2013AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 23, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, August 7, 2007PUBLISHED FOR OPPOSITION
Wednesday, July 18, 2007NOTICE OF PUBLICATION
Thursday, July 5, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, June 22, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 7, 2007EXAMINERS AMENDMENT MAILED
Thursday, June 7, 2007EXAMINER'S AMENDMENT ENTERED
Thursday, June 7, 2007EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 16, 2007AMENDMENT FROM APPLICANT ENTERED
Wednesday, April 25, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 16, 2007ASSIGNED TO LIE
Wednesday, April 25, 2007PAPER RECEIVED
Friday, November 3, 2006FINAL REFUSAL MAILED
Friday, November 3, 2006FINAL REFUSAL WRITTEN
Thursday, October 12, 2006AMENDMENT FROM APPLICANT ENTERED
Monday, September 25, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 25, 2006PAPER RECEIVED
Friday, March 24, 2006NON-FINAL ACTION MAILED
Friday, March 24, 2006NON-FINAL ACTION WRITTEN
Wednesday, November 9, 2005NON-FINAL ACTION MAILED
Tuesday, November 8, 2005NON-FINAL ACTION WRITTEN
Monday, November 7, 2005ASSIGNED TO EXAMINER
Wednesday, April 20, 2005NEW APPLICATION ENTERED IN TRAM